Posts Tagged ‘Dr. Nicholas Peppas’

Nicholas Peppas Wins Prestigious AAPS Pharmaceutical Scientist Award

Posted on:
Nicholas Peppas Wins Prestigious AAPS Pharmaceutical Scientist Award Nicholas Peppas has been named the 2018 American Assoc. of Pharmaceutical Scientists’ Distinguished Award winner for his work in protein and drug transport. 

Nicholas Peppas Honored by National Academy of Medicine for Outstanding Service

Posted on:
Nicholas Peppas Honored by National Academy of Medicine for Outstanding Service Nicholas Peppas has received the Adam Yarmolinsky Medal from the National Academy of Medicine (NAM). Peppas is the first engineer to receive this award, which is one of three prestigious medals that NAM awards to its members.

Justin Zhong receives Student Award for Outstanding Undergraduate Research

Posted on:
Justin Zhong receives Student Award for Outstanding Undergraduate Research Texas ChE senior, Justin Zhong, is the recipient of the 2018 Student Award for Outstanding Undergraduate Research from the Society for

Top 10 Highlights of 2017

Posted on:
Top 10 Highlights of 2017 As 2017 winds down, we celebrate some of this year's top highlights.

Nicholas Peppas Elected to American Academy of Arts and Sciences  

Posted on:
Nicholas Peppas Elected to American Academy of Arts and Sciences  

Nicholas Peppas, professor in the McKetta Department of Chemical Engineering at The University of Texas at Austin and an expert in biomaterials and drug delivery systems, has been elected to the American Academy of Arts and Sciences.

Peppas is one of 228 new members elected this year. They include some of the world’s most … Read the rest »

Peppas Receives NIH Funding to Improve Early Detection of Autoimmune Disorders

Posted on:
Peppas Receives NIH Funding to Improve Early Detection of Autoimmune Disorders

Originally published on the Department of Biomedical Engineering’s website.

Treatment of autoimmune disorders is most effective when they are diagnosed early. In Sjögren’s syndrome, an autoimmune disease that affects the exocrine system, patients suffer from dry eye and dry mouth. Diagnosis is often delayed by six to ten years even after symptoms appear. Currently, … Read the rest »

FDA Approves Hepatitis C Treatment Co-Invented by Texas ChE Ph.D. Student

Posted on:
FDA Approves Hepatitis C Treatment Co-Invented by Texas ChE Ph.D. Student

Today the U.S. Food and Drug Administration approved the drug product Zepatier for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Texas ChE Ph.D. student Angela Wagner of Professor Nicholas Peppas’ research group was one of the team of eight researchers to co-invent and patent Zepatier.

Hepatitis … Read the rest »

Peppas Receives Courtesy Appointment in Dell Medical School

Posted on:

Nicholas Peppas Receives International Award from European Society for Biomaterials

Posted on:

New Institute Advances Health Care Solutions

Posted on:
New Institute Advances Health Care Solutions

The Cockrell School of Engineering at The University of Texas at Austin is launching the university’s first health care engineering institute dedicated to developing technologies and treatments that will immediately improve patient quality of life.

Led by Nicholas Peppas, a professor in the McKetta Department of Chemical Engineering, the College of Pharmacy, the Department … Read the rest »